Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Optical Valley Humanwell Biological Pharmaceutical is a specialized biotechnology subsidiary of Humanwell Healthcare Group, located in the Wuhan East Lake High-tech Development Zone (Optical Valley). The company focuses on the research, development, and industrialization of high-end biological drugs, including recombinant proteins and monoclonal antibodies. Its portfolio primarily targets therapeutic areas such as hematology, respiratory diseases, and metabolic disorders. The firm operates advanced R&D facilities and manufacturing lines designed to meet international GMP standards. By leveraging the resources of its parent group, it aims to bring innovative biological therapies to both the Chinese and global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Optical Valley Humanwell Biological Pharmaceutical.